Kevin F. McLaughlin

Insider Reports History

Location
Cambridge, MI
Signature
/s/ Jill Andersen attorney-in-fact for Kevin F. McLaughlin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin F. McLaughlin:

Form 4 holding Director

Invivyd, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
Report date
19 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vericel Corp

Security class
Stock Option (Right to Buy)
Shares / value
14,000
Estimated value
Report date
13 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vericel Corp

Security class
Restricted Stock Unit
Shares / value
3,200
Estimated value
Report date
29 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, CFO and Treasurer

ACCELERON PHARMA INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
19 Nov 2021
Price
$29.37
Ownership
Direct
Form 4 holding SVP, CFO and Treasurer

ACCELERON PHARMA INC

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
19 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Decibel Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
25 Sep 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kevin F. McLaughlin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .